The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Abbvie
Honoraria - Celgene
Consulting or Advisory Role - Adaptive Biotechnologies; Janssen; Takeda
Research Funding - Celgene
 
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Janssen
Speakers' Bureau - Celgene; Janssen
Travel, Accommodations, Expenses - Celgene; Janssen
 
Honoraria - Amgen; Celgene; Janssen-Cilag
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Takeda
Research Funding - Amgen; Celgene; Sanofi
Efficacy and safety of daratumumab, bortezomib, and dexamethasone (D-Vd) in relapsed or refractory multiple myeloma (RRMM) based on cytogenetic risk: Updated subgroup analysis of CASTOR.
 
Katja Weisel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Sanofi; Takeda
Research Funding - Amgen; Celgene; Janssen; Sanofi
 
Andrew Spencer
Honoraria - Amgen; Celgene; Janssen; Servier; Takeda
Consulting or Advisory Role - Abbvie; Celgene; Janssen; Servier
Speakers' Bureau - Celgene; Janssen; Takeda
Research Funding - Celgene; Janssen; Takeda
 
Suzanne Lentzsch
Stock and Other Ownership Interests - Caelum Biosciences
Consulting or Advisory Role - Bristol-Myers Squibb; Caelum Biosciences; Janssen; Novartis
Patents, Royalties, Other Intellectual Property - Sanofi
Travel, Accommodations, Expenses - Janssen
Other Relationship - Sorrento Therapeutics
 
Herve Avet-Loiseau
No Relationships to Disclose
 
Tomer M. Mark
No Relationships to Disclose
 
Ivan Spicka
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Research Funding - Amgen; Celgene
 
Alberto Bosi
Honoraria - Amgen
Consulting or Advisory Role - Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen
 
Vania TM Hungria
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
 
Michele Cavo
No Relationships to Disclose
 
Je-Jung Lee
No Relationships to Disclose
 
Ajay K. Nooka
Consulting or Advisory Role - Adaptive technologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Spectrum Pharmaceuticals; Takeda
 
Hang Quach
No Relationships to Disclose
 
Markus Munder
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Heidelberg Pharma; Janssen; Takeda
Research Funding - Bristol-Myers Squibb; Incyte
 
Meral Beksac
Consulting or Advisory Role - Amgen (Inst); Celgene (Inst); Janssen-Cilag (Inst); Takeda (Inst)
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag
 
Pieter Sonneveld
Honoraria - Celgene
Consulting or Advisory Role - Celgene
 
David Soong
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Jon Ukropec
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Ming Qi
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Maria-Victoria Mateos
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda